Jong Kim - ABL Bio MD Devel
| 298380 Stock | KRW 27,200 300.00 1.09% |
Insider
Jong Kim is MD Devel of ABL Bio
| Phone | 82 31 8018 9800 |
| Web | http://www.ablbio.com |
ABL Bio Management Efficiency
The company has return on total asset (ROA) of (0.3051) % which means that it has lost $0.3051 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 5.5983 %, meaning that it generated $5.5983 on every $100 dollars invested by stockholders. ABL Bio's management efficiency ratios could be used to measure how well ABL Bio manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 8 records | INSIDER Age | ||
| You Suh | Genexine | N/A | |
| JaiHyun Kwon | Genexine | N/A | |
| Young Sung | Genexine | 67 | |
| Jae Park | Genexine | N/A | |
| Kyu Kim | Genexine | N/A | |
| Sung CPA | Genexine | N/A | |
| Jungwon Woo | Genexine | N/A | |
| Sung Lee | Genexine | N/A | |
Management Performance
| Return On Equity | 5.6 | |||
| Return On Asset | -0.31 |
ABL Bio Leadership Team
Elected by the shareholders, the ABL Bio's board of directors comprises two types of representatives: ABL Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ABL. The board's role is to monitor ABL Bio's management team and ensure that shareholders' interests are well served. ABL Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ABL Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jung Kim, MD COO | ||
| Jaecheon Lee, MD CFO | ||
| Jae Jung, MD Discovery | ||
| Jong Kim, MD Devel | ||
| Sang Lee, Founder CEO | ||
| You WeonKyoo, Head MD | ||
| Jong Won, Head Devel |
ABL Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ABL Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 5.6 | |||
| Return On Asset | -0.31 | |||
| Operating Margin | (6.16) % | |||
| Current Valuation | 866.33 B | |||
| Shares Outstanding | 45.3 M | |||
| Shares Owned By Insiders | 31.53 % | |||
| Shares Owned By Institutions | 12.89 % | |||
| Price To Sales | 101.38 X | |||
| Revenue | 5.33 B | |||
| Gross Profit | 8.06 B |
Pair Trading with ABL Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ABL Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABL Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with ABL Stock
| 0.62 | 207940 | Samsung Biologics | PairCorr |
| 0.91 | 326030 | Sk Biopharmaceuticals | PairCorr |
| 0.65 | 144510 | Green Cross Lab | PairCorr |
Moving against ABL Stock
The ability to find closely correlated positions to ABL Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ABL Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ABL Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ABL Bio to buy it.
The correlation of ABL Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ABL Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ABL Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ABL Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in ABL Stock
ABL Bio financial ratios help investors to determine whether ABL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ABL with respect to the benefits of owning ABL Bio security.